Abvc Biopharma (ABVC) Return on Invested Capital (2019 - 2026)

Abvc Biopharma (ABVC) has 8 years of Return on Invested Capital data on file, last reported at 0.03% in Q1 2026.

• Quarterly Return on Invested Capital fell 2.0% year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (down 2.0% YoY) and the FY2025 annual result came in at 0.09%, down 4.0% from the prior year.
• Return on Invested Capital slipped to 0.03% in Q1 2026, from 0.02% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q1 2025 to a low of 0.12% in Q3 2022.
• A 5-year average of 0.04% and a median of 0.03% in 2026 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2022 — Return on Invested Capital declined 9 bps — and 2023, when it increased 8 bps.
• Tracing ABVC's Return on Invested Capital over 5 years: stood at 0.06% in 2022, then soared by 46 bps to 0.03% in 2023, then jumped by 60 bps to 0.01% in 2024, then plunged by 56 bps to 0.02% in 2025, then slipped by 26 bps to 0.03% in 2026.
• The last three Return on Invested Capital figures came in at 0.03% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.